Conway Capital Management, Inc. Olema Pharmaceuticals, Inc. Transaction History
Conway Capital Management, Inc.
- $200 Billion
- Q1 2025
A detailed history of Conway Capital Management, Inc. transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Conway Capital Management, Inc. holds 10,000 shares of OLMA stock, worth $52,800. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$52,800
Previous $58.3 Million
35.51%
% of portfolio
0.02%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding OLMA
# of Institutions
135Shares Held
64.3MCall Options Held
6.3KPut Options Held
15.2K-
Bain Capital Life Sciences Investors, LLC Boston, MA6.84MShares$36.1 Million8.64% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.74MShares$35.6 Million1.3% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$28 Million0.88% of portfolio
-
Black Rock Inc. New York, NY4MShares$21.1 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.44MShares$18.2 Million0.45% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $213M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...